BARC/PUB/2016/0984
Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: Is redifferentiation akin phenomenon a reality in neuroendocrine tumors?
Basu, Sandip; Ostwal, V. (RMC)
Nuclear Medicine Communications, 2016. Vol. 37 (6): pp. 669-671
Abstract not available.